Effective treatment of orthotopic liver cancer with bifunctional embolization microspheres
Acta Biomaterialia · 2026-10
DOI: 10.1016/j.actbio.2026.10.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-10. Verfasst von Baoqu Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, China; State Ke…. Die Arbeit nennt 83 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Transcatheter arterial chemoembolization (TACE) is a minimally invasive procedure used widely for the treatment of unresectable hepatocellular carcinoma (HCC). However, embolization-induced hypoxia upregulates VEGF, and the resulting angiogenic response contributes to tumor recurrence, further limiting the efficacy of TACE against HCC. Herein, we present a multifunctional embolic microsphere system in which sorafenib (SRF) and calcium carbonate (CaCO3) nanoparticles are rationally encapsulated within sodium hyaluronate microspheres (SRF-CaCO3@SH MSs) via microfluidic technology. The microspheres exhibited a bowl-shaped morphology with tunable diameters, which enhances in vivo embolic stability through mechanical interlocking between adjacent microspheres. In an acidic tumor microenvironment (TME), pH-triggered release of Ca²⁺ (23.9%) and SRF (65.7%) far exceeded neutral conditions. SRF-CaCO3@SH MSs maintained >85% HUVEC viability and reduced VX2 cell viability to 24.3%, showing maximal cytotoxicity under acidic conditions. After intra-arterial injection, the microspheres occluded tumor-feeding arteries; Ca²⁺ released in the acidic TME inhibited angiogenesis, and CaCO3 neutralized TME acidity, counteracting immunosuppression. In a rabbit VX2 orthotopic HCC model, DSA-guided TACE achieved effective occlusion, slowest tumor growth, largest necrosis, and marked downregulation of CD31, Ki67, and VEGF, without systemic toxicity. Combining morphological design, pH-responsive occlusion, TME neutralization, and anti-angiogenesis, this embolic system synergistically enhances TACE and shows strong clinical potential. STATEMENT OF SIGNIFICANCE: Conventional liver cancer embolization frequently fails due to hypoxia-driven angiogenesis and subsequent tumor recurrence. We developed a dual-functional embolic microsphere (SRF-CaCO3@SH MS) that integrates stable vascular occlusion with active modulation of the tumor microenvironment. Utilizing microfluidics, we fabricated bowl-shaped sodium hyaluronate microspheres that mechanically interlock to ensure durable embolization. Under acidic tumor conditions, calcium carbonate neutralizes pH and releases Ca²⁺, which synergizes with sorafenib to inhibit angiogenesis and induce apoptosis. In a rabbit orthotopic HCC model, this system demonstrated superior tumor control and necrosis without inducing systemic toxicity. This work presents a microenvironment-responsive embolization strategy integrating durable vascular occlusion, pH modulation, and anti-angiogenic therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou, 310018, China; State Key Laboratory of Bio-based Fiber Materials, Zhejiang Sci-Tech Universit…
- Department of Interventional Radiology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310000, China.
- Department of Interventional Radiology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310000, China. Electronic address: tangrui8700@zju.edu.cn.
Förderung
- Natural Science Foundation of Zhejiang Province
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, B., Li, J., Zhao, J., Peng, Y., Kannan, P. R., Zhang, H., Kong, X., Tang, R., & Zhao, R. (2026). Effective treatment of orthotopic liver cancer with bifunctional embolization microspheres. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2026.10.017
Vancouver
Zhang B, Li J, Zhao J, Peng Y, Kannan PR, Zhang H, et al. Effective treatment of orthotopic liver cancer with bifunctional embolization microspheres. Acta Biomaterialia. 2026. doi:10.1016/j.actbio.2026.10.017
BibTeX
@article{Zhang2026,
author = {Zhang, Baoqu and Li, Jianke and Zhao, Jianmin and Peng, Yanwu and Kannan, Perumal Ramesh and Zhang, Han and Kong, Xiangdong and Tang, Rui and Zhao, Ruibo},
title = {Effective treatment of orthotopic liver cancer with bifunctional embolization microspheres},
journal = {Acta Biomaterialia},
year = {2026},
doi = {10.1016/j.actbio.2026.10.017}
}
EUVIMED